Bupropion Hydrochloride is used as an antidepressant medication to treat major depressive disorder and seasonal affective disorder
Drug firm Granules India announced that it has received US FDA approval to market Bupropion Hydrochloride extended-release tablets, an antidepressant medication to treat major depressive disorder and seasonal affective disorder. "Granules Pharmaceuticals, Inc (GPI), a wholly-owned subsidiary of the company, has received approval from the US Food & Drug Administration (USFDA) to market the product in strengths of 150 mg and 300 mg," the drug firm said in a statement. The company
